case_images: PMC11824715_01
case_images: Clinical images of the patient with FHH3. (A) An ultrasonographic image of the neck. (B) The posterior view of the spinal radiograph showing scoliosis. (C) The three-dimensional computed tomography image of the patient. FHH3, Familial hypocalciuric hypercalcemia type 3.
case_images: CRIE2025-9514578.001.jpg
case_images: PMC11824715_01_CRIE2025-9514578.001.jpg
case_images: fig1
case_images: Thyroid ultrasonography revealed no enlarged parathyroid glands (Figure 1A). Scoliosis was observed on radiography and three-dimensional CT (Figure 1B,C).
case_images: Changes in the serum level of calcium and fractional excretion of Ca before and during treatment with evocalcet. Ca, calcium.
case_images: CRIE2025-9514578.002.jpg
case_images: PMC11824715_01_CRIE2025-9514578.002.jpg
case_images: fig2
case_images: After initiating treatment with evocalcet, the serum Ca level gradually decreased (Figure 2). With a gradual increase in medication dose, oral administration of evocalcet (7 mg/day) normalized the serum Ca level (Figure 2). In parallel with the change in the serum Ca level, the FECa increased (Figure 2), whereas the level of intact PTH remained within normal limits.